arBtrage CAPITALIZING MARKETS checking… Sign in

Citius Pharmaceuticals, Inc.

CTXR Health Care Biotechnology: Pharmaceutical Preparations
$0.56
▼ -5.0% Today
as of Jun 7, 07:12 ET
Last 30 days -13.85% Apr 28 → Jun 05
$0.51 $0.57 $0.62 $0.68 $0.74 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$0.60
High
$0.61
Low
$0.56
Volume
$257,400
Avg Vol
$1M
Mkt Cap
$18M
P/E (TTM)
Beta
52w High
$2.48
52w Low
$0.48
Div Yield
Shares Out
$22M

Overview

52-week range
$0.48
$2.48
4% of range
Avg surprise (last 1)
-17.6%
Avg reaction (last 2)
+8.2%
50% positive
Latest IV / EM
5028%
EM ±696.4% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.57$-1.19$-0.82$-0.44$-0.06 Actual $-0.06Actual $-1.45Actual $-1.34Actual $-1.57Actual $-1.30Actual $-1.27Est $-1.08Actual $-0.80Actual $-0.38Actual $-0.95 JunDecMarJunDecMar/2025JunDecMar/2026
Revenue vs Net Income Revenue Net income
$-12M$-8M$-4M$228,111$4M Jun 24Dec 24Mar 25Dec 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Fri May 15, 2026Mar/2026 $-0.95 +25.2% -2.8% earnings
Wed Dec 31, 2025Dec 2025 $-0.38 financials
Mon Jun 30, 2025Jun 2025 $-0.80 financials
Wed May 14, 2025Mar/2025 $-1.27 $-1.08 -17.6% +19.2% earnings
Tue Dec 31, 2024Dec 2024 $-1.30 financials
Sun Jun 30, 2024Jun 2024 $-1.57 financials
Sun Mar 31, 2024Mar 2024 $-1.34 financials
Sun Dec 31, 2023Dec 2023 $-1.45 financials
Fri Jun 30, 2023Jun 2023 $-0.06 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$2M$4M
Cost of revenue$328,878$789,208
Gross profit$1M$3M
Operating income$-32M$-9M$-9M$-11M$-10M$-11M
Net income$-12M$-10M$-11M
EPS (diluted)$-0.95$-0.38$-0.80$-1.27$-1.30$-1.57

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$5M$8M$4M$6M$26,410$1M$3M$18M
Inventory$23M$23M$22M$17M$15M$14M$8M
Total current assets$32M$38M$28M$25M$18M$18M$14M$28M
Total assets$133M$140M$131M$128M$121M$121M$117M$97M
Long-term debt
Total liabilities$63M$47M$53M$60M$58M$52M$43M$11M
Total equity$62M$80M$68M$65M$61M$65M$70M$86M

Implied volatility — last 90 days

5022%5025%5027%5030%5032% Jun 07 — IV 5028% · EM ±696.4%

Sector peers